维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Jerling M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Clinical pharmacokinetics of ranolazine 显示文摘	Jerling M	2006	Clin Pharmacokinet2006，45，5：	1
2	Studies to investigate the pharmacokinetic interactions between ranolazine and Ketoconazole,Diltiazem,or Simvastatin during combined administration in healthy subjects显示文摘	Jerling M Huan BL Leung K	2005	J Clin Pharmacol2005，45，4：	1
3	Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial显示文摘	Hornestam B Jerling M Karlsson M O	2003	Eur J Clin Pharmacol2003，58，11：	1
4	Hanekom SM clus2tering of haemostatic ariables and the effect of high cashew and walnut diets on these variables in metabolic syndrome patients 显示文摘	Pieters M Oosthuizen W Jerling JC	2005	Blood Coagul Fibrinolysis2005，16，06：	1
5	Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in health subjects显示文摘	JERLING M HUAN BL LEUNG K	2005	J Clin Pharmacol2005，45，4：	1
6	The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol&ast显示文摘	Jerling M Dahl ML Aberg-Wistedt A	1996	Clin Pharmacol Ther1996，59，4：	1
7	Clinical pharmacokinetics of ranolazine显示文摘	Jerling M	2006	Clin Pharmaeokinet2006，45，5：	1
8	Hanekom SM clus2tering of haemostatic ariables and the effect of high cashew and walnut diets on these variables in meta- bolic syndrome patients 显示文摘	Pieters M Oosthuizen W Jerling JC	2005	Blood Coagul Fibrinolysis2005，16，6：	1
9	Clinical pharmacokinetics of ranolazine 显示文摘	Jerling M	2006	Clin Phar- macokinet2006，45，：	1
10	Studies to investigate the phar- macokinetic interactions between ranolazine and ketoconazole, dilti- azem or simvastatin during combined administration in healthy sub- jects 显示文摘	Jerling M Huan BL Leung K	2005	Clin Pharmacol2005，45，：	1
11	Studies to investigate the phar- macokinetic interactions between ranolazine and ketoconazole, dilti- azem or simvastatin during combined administration in healthy sub- jects 显示文摘	Jerling M Huan BL Leung K	2005	Clin Pharmacol2005，45，42：	1
12	Hanekom SM clustering of haemostatie ariables and the effect of high cashew and walnut diets on these variables in metabolic syndrome patients 显示文摘	PIETERS M OOSTHUIZEN W JERLING J C	2005	Blood Coagul Fibrin2005，16，6：	1
13	Clinical pharmacokinetics of ranolazine 显示文摘	Jerling M	2006	Clin Pharmaeokinet2006，45，5：	1
14	Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine显示文摘	JERLING M ABDALLAH H	2005	Clin Pharmacol Ther2005，78，3：	1
15	Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustainedrelease tablets显示文摘	ABDALLAH H JERLING M	2005	J Clin Pharmacol2005，45，7：	1
16	Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects显示文摘	Jerling M Huan BL Leung K	2005	J Clin Phar- macol2005，45，4：	1
17	Fluvoxamine inhibition and carbamazepine induction of the metabalism of clozapine: evdence from a therapentic drug monitoring service 显示文摘	Jerling M Lindstrom L Bondesson U	1994	Ther Drug Monit1994，16，：	1
18	Clinical pharmacokinetics of ranolazine显示文摘	Jerling M	2006	Clin Pharma-cokinet2006，45，：	1
19	Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets显示文摘	ABDALLAH H JERLING M	2005	Clin Pharmacol2005，45，：	1
20	The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol显示文摘	Jerling M Dahl ML Aberg-Wistedt A	1996	Clin Pharmacol Ther1996，59，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示